- Home
- NRSN vs SST Comparison
NRSN vs SST Comparison
Compare NRSN & SST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRSN | SST |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.5M | 34.9M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | NRSN | SST |
|---|---|---|
| Price | $1.02 | $3.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $14.00 | $10.00 |
| AVG Volume (30 Days) | ★ 225.5K | 6.8K |
| Earning Date | 03-20-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $289,784,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.68 | $2.90 |
| 52 Week High | $2.60 | $15.00 |
Technical Indicators
Market Signals| Indicator | NRSN | SST |
|---|---|---|
| Relative Strength Index (RSI) | 56.84 | 34.79 |
| Support Level | $0.95 | $3.26 |
| Resistance Level | $1.06 | $4.25 |
| Average True Range (ATR) | 0.07 | 0.20 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 77.15 | 11.29 |
Price Performance
Historical ComparisonAbout NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.